Fusion Pharmaceuticals Inc.
FUSNDelisted Jun 5, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001805890
Fusion Pharmaceuticals Inc. was delisted on Jun 5, 2024; its insiders filed their last Form 4 on Jun 4, 2024; 114 institutions reported holding it in 13F filings for Q1 2024, worth $1.47B in total; Duquesne Family Office was the only superinvestor holding it.
13F holders, Q1 2023
Institutional positions in Fusion Pharmaceuticals Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- +8 vs. Q4 2022
- Shares held
- 45.6M
- +17.4M (+61.5%) vs. Q4 2022
- Total value
- $171.9M
- +$83.0M (+93.3%) vs. Q4 2022
- New holders
- 12
- 6 more added
- Sold out
- 4
- 5 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FUSN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 114 | $1.47B |
| Q4 2023 | 77 | $584.1M |
| Q3 2023 | 41 | $129.8M |
| Q2 2023 | 41 | $235.1M |
| Q1 2023 | 38 | $171.9M |
| Q4 2022 | 30 | $88.9M |
| Q3 2022 | 34 | $80.3M |
| Q2 2022 | 31 | $69.4M |
| Q1 2022 | 28 | $219.1M |
| Q4 2021 | 32 | $116.0M |
| Q3 2021 | 40 | $220.6M |
| Q2 2021 | 39 | $221.8M |
| Q1 2021 | 38 | $295.9M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Fusion Pharmaceuticals Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 2 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 30 | $113 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 459 | $1.00K | 0.00% | +459 | New |
| Signaturefd, LLC | 300 | $1.13K | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 700 | $2.63K | 0.00% | −175−20.0% | Reduced |
| Royal Bank of Canada | 2,203 | $8.00K | 0.00% | +1,353+159.2% | Added |
| BlackRock Inc. | 8,253 | $31.1K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 13,084 | $49.0K | 0.01% | +13,084 | New |
| Schonfeld Strategic Advisors LLC | 13,100 | $49.4K | 0.00% | +13,100 | New |
| Geode Capital Management, LLC | 25,136 | $94.8K | 0.00% | 00.0% | Unchanged |
| Leonteq Securities AG | 35,000 | $131.9K | 0.01% | −18,000−34.0% | Reduced |
| Two Sigma Advisers, LP | 35,900 | $135.3K | 0.00% | +35,900 | New |
| Tekla Capital Management LLC | 43,394 | $163.6K | 0.01% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 44,827 | $169.0K | 0.00% | +44,827 | New |
| Sectoral Asset Management Inc | 57,297 | $216.0K | 0.04% | 00.0% | Unchanged |
| UBS Group AG | 89,786 | $338.5K | 0.00% | +27,110+43.3% | Added |
| Sofinnova Investments, Inc. | 117,099 | $441.5K | 0.03% | 00.0% | Unchanged |
| Morgan Stanley | 118,235 | $445.7K | 0.00% | +10,287+9.5% | Added |
| UBS Oconnor LLC | 242,026 | $912.4K | 0.02% | +242,026 | New |
| Sio Capital Management, LLC | 246,036 | $927.6K | 0.46% | −14,412−5.5% | Reduced |
| Point72 Asset Management, L.P. | 328,868 | $1.24M | 0.00% | 00.0% | Unchanged |
| Ghost Tree Capital, LLC | 350,000 | $1.32M | 0.50% | +350,000 | New |
| Millennium Management LLC | 403,788 | $1.47M | 0.00% | +403,788 | New |
| Ra Capital Management, L.P. | 659,992 | $2.49M | 0.06% | 00.0% | Unchanged |
| 1832 Asset Management L.P. | 734,321 | $2.77M | 0.01% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 1,283,537 | $4.84M | 1.05% | +1,283,537 | New |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,560,982 | $5.88M | 2.42% | −20.0% | Reduced |
| Artal Group S.A. | 1,975,000 | $7.45M | 0.44% | +1,225,000+163.3% | Added |
| TPG GP A, LLC | 2,551,794 | $9.62M | 0.16% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 2,759,936 | $10.4M | 0.31% | +2,759,936 | New |
| Deerfield Management Company, L.P. (Series C) | 2,823,000 | $10.6M | 0.24% | +2,823,000 | New |
| Adams Street Partners LLC | 2,947,809 | $11.1M | 3.47% | 00.0% | Unchanged |
| Canada Pension Plan Investment Board | 3,116,966 | $11.8M | 0.02% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 3,122,770 | $11.8M | 0.23% | −102,000−3.2% | Reduced |
| Johnson & Johnson | 3,670,516 | $13.8M | 4.50% | 00.0% | Unchanged |
| FMR LLC | 4,681,457 | $17.6M | 0.00% | +1,989,403+73.9% | Added |
| Avidity Partners Management LP | 5,700,000 | $21.5M | 0.71% | +5,700,000 | New |
| Federated Hermes, Inc. | 5,849,100 | $22.1M | 0.06% | +2,625,000+81.4% | Added |
| Braidwell LP | 0 | $0 | 0.00% | −2,000,000−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −23,500−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −12,510−100.0% | Sold out |
| Truvestments Capital LLC | 0 | $0 | 0.00% | −335−100.0% | Sold out |